ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Price:
2 471
JPY
0.86%
Market Cap:
¥71.1B
Income Statement
Earnings Waterfall
ASKA Pharmaceutical Holdings Co Ltd
ASKA Pharmaceutical Holdings Co Ltd
Income Statement
ASKA Pharmaceutical Holdings Co Ltd
ASKA Pharmaceutical Holdings Co Ltd
Currency: JPY
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||
| Interest Expense |
62
|
60
|
59
|
59
|
59
|
58
|
56
|
55
|
52
|
51
|
50
|
48
|
46
|
43
|
40
|
40
|
41
|
44
|
51
|
0
|
0
|
0
|
|
| Revenue |
53 363
N/A
|
54 685
+2%
|
55 181
+1%
|
55 688
+1%
|
56 255
+1%
|
56 010
0%
|
56 607
+1%
|
57 655
+2%
|
58 302
+1%
|
59 687
+2%
|
60 461
+1%
|
61 215
+1%
|
61 937
+1%
|
62 026
+0%
|
62 843
+1%
|
63 172
+1%
|
63 566
+1%
|
63 945
+1%
|
64 139
+0%
|
67 108
+5%
|
67 021
0%
|
68 699
+3%
|
|
| Gross Profit | |||||||||||||||||||||||
| Cost of Revenue |
(28 596)
|
(28 905)
|
(29 798)
|
(29 689)
|
(30 286)
|
(30 260)
|
(30 255)
|
(30 741)
|
(31 074)
|
(31 663)
|
(31 876)
|
(32 418)
|
(32 467)
|
(32 176)
|
(32 178)
|
(31 800)
|
(32 180)
|
(32 453)
|
(32 803)
|
(35 314)
|
(34 607)
|
(35 495)
|
|
| Gross Profit |
24 767
N/A
|
25 780
+4%
|
25 383
-2%
|
25 999
+2%
|
25 969
0%
|
25 750
-1%
|
26 352
+2%
|
26 914
+2%
|
27 228
+1%
|
28 024
+3%
|
28 585
+2%
|
28 797
+1%
|
29 470
+2%
|
29 850
+1%
|
30 665
+3%
|
31 372
+2%
|
31 386
+0%
|
31 492
+0%
|
31 336
0%
|
31 794
+1%
|
32 414
+2%
|
33 204
+2%
|
|
| Operating Income | |||||||||||||||||||||||
| Operating Expenses |
(22 921)
|
(22 747)
|
(21 774)
|
(22 108)
|
(21 649)
|
(21 240)
|
(21 557)
|
(29 785)
|
(23 471)
|
(22 641)
|
(23 477)
|
(23 649)
|
(24 186)
|
(24 257)
|
(24 165)
|
(24 818)
|
(24 596)
|
(25 023)
|
(26 005)
|
(25 785)
|
(26 822)
|
(27 500)
|
|
| Selling, General & Administrative |
(22 060)
|
(22 016)
|
(21 773)
|
(22 099)
|
(21 647)
|
(21 240)
|
(17 958)
|
(21 642)
|
(22 210)
|
(22 863)
|
(19 249)
|
(23 648)
|
(24 184)
|
(24 256)
|
(19 436)
|
(24 818)
|
(24 595)
|
(25 022)
|
(18 972)
|
(26 740)
|
(27 777)
|
(28 455)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(3 598)
|
0
|
0
|
0
|
(4 227)
|
0
|
0
|
0
|
(4 728)
|
0
|
0
|
0
|
(7 031)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(861)
|
(731)
|
(1)
|
(9)
|
0
|
0
|
(1)
|
(8 143)
|
(1 261)
|
222
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(2)
|
955
|
955
|
955
|
|
| Operating Income |
1 846
N/A
|
3 033
+64%
|
3 609
+19%
|
3 891
+8%
|
4 320
+11%
|
4 510
+4%
|
4 795
+6%
|
(2 871)
N/A
|
3 757
N/A
|
5 383
+43%
|
5 108
-5%
|
5 148
+1%
|
5 284
+3%
|
5 593
+6%
|
6 500
+16%
|
6 554
+1%
|
6 790
+4%
|
6 469
-5%
|
5 331
-18%
|
6 009
+13%
|
5 592
-7%
|
5 704
+2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||
| Interest Income Expense |
172
|
177
|
216
|
738
|
725
|
690
|
202
|
166
|
235
|
408
|
369
|
456
|
2 659
|
3 137
|
3 542
|
3 426
|
1 176
|
484
|
192
|
205
|
61
|
(63)
|
|
| Non-Reccuring Items |
0
|
0
|
(8)
|
0
|
(6 890)
|
(8 374)
|
(8 142)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
957
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
9 425
|
9 382
|
0
|
0
|
0
|
(52)
|
0
|
0
|
0
|
(13)
|
0
|
(114)
|
(119)
|
(106)
|
(10)
|
19
|
96
|
|
| Total Other Income |
(83)
|
(730)
|
(242)
|
(712)
|
(671)
|
(54)
|
(74)
|
9 344
|
9 329
|
(110)
|
(68)
|
(179)
|
(195)
|
(220)
|
(167)
|
(178)
|
(88)
|
(46)
|
(182)
|
(109)
|
(36)
|
(41)
|
|
| Pre-Tax Income |
1 935
N/A
|
2 480
+28%
|
3 575
+44%
|
3 917
+10%
|
(2 516)
N/A
|
6 197
N/A
|
6 163
-1%
|
6 639
+8%
|
13 321
+101%
|
5 681
-57%
|
5 357
-6%
|
5 425
+1%
|
7 748
+43%
|
8 510
+10%
|
9 862
+16%
|
9 802
-1%
|
7 764
-21%
|
6 788
-13%
|
6 192
-9%
|
6 095
-2%
|
5 636
-8%
|
5 696
+1%
|
|
| Net Income | |||||||||||||||||||||||
| Tax Provision |
(311)
|
(445)
|
(861)
|
(843)
|
881
|
(1 851)
|
(1 873)
|
(2 125)
|
(3 888)
|
(1 291)
|
(1 118)
|
(1 080)
|
(1 725)
|
(1 996)
|
(2 316)
|
(2 411)
|
(1 788)
|
(1 602)
|
(1 091)
|
(924)
|
(713)
|
(664)
|
|
| Income from Continuing Operations |
1 624
|
2 035
|
2 714
|
3 074
|
(1 635)
|
4 346
|
4 290
|
4 514
|
9 433
|
4 390
|
4 239
|
4 345
|
6 023
|
6 514
|
7 546
|
7 391
|
5 976
|
5 186
|
5 101
|
5 171
|
4 923
|
5 032
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(99)
|
(155)
|
(124)
|
|
| Net Income (Common) |
1 624
N/A
|
2 036
+25%
|
2 713
+33%
|
3 072
+13%
|
(1 635)
N/A
|
4 344
N/A
|
4 290
-1%
|
4 515
+5%
|
9 432
+109%
|
4 391
-53%
|
4 238
-3%
|
4 343
+2%
|
6 021
+39%
|
6 513
+8%
|
7 545
+16%
|
7 390
-2%
|
5 976
-19%
|
5 185
-13%
|
5 101
-2%
|
5 072
-1%
|
4 767
-6%
|
4 907
+3%
|
|
| EPS (Diluted) |
57.28
N/A
|
71.81
+25%
|
95.69
+33%
|
108.25
+13%
|
-57.56
N/A
|
152.89
N/A
|
151.22
-1%
|
160.18
+6%
|
334.07
+109%
|
155.37
-53%
|
150.08
-3%
|
153.53
+2%
|
212.66
+39%
|
229.93
+8%
|
266.49
+16%
|
260.86
-2%
|
210.87
-19%
|
182.82
-13%
|
179.94
-2%
|
178.82
-1%
|
167.95
-6%
|
172.81
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
